Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts

Neurol Med Chir (Tokyo). 2022 Feb 15;62(2):65-74. doi: 10.2176/nmc.oa.2020-0439. Epub 2021 Nov 12.

Abstract

Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease.

Keywords: myelopathy; spinal arteriovenous shunts; steroid.

MeSH terms

  • Arteriovenous Fistula* / complications
  • Embolization, Therapeutic* / adverse effects
  • Humans
  • Retrospective Studies
  • Spinal Cord Diseases* / etiology
  • Spinal Cord Diseases* / therapy